ADAR1 Capital Management »

Masimo Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Masimo Corporation (MASI) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Masimo Corporation

Tip: Access up to 7 years of quarterly data

All positions including Masimo Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Masimo Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.6k 38 146.84
2023-12-31 $6.8k 58 117.21

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Masimo Corporation

BlackRock
BlackRock
Vanguard Group
Politan Capital Management
T. Rowe Price Investment Management
State Street Corporation
Westfield Capital Management Company
Capital Research Global Investors
Farallon Capital Management
Ace Management Global
Holocene Advisors
Liontrust Investment Partners
Geode Capital Management
Massachusetts Financial Services
Alyeska Investment Group

View all funds holding Masimo Corporation